Asmerom Tesfamariam Sengal

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersObstetrics and gynaecologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 07, 2023
Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.

Asmerom T Sengal, Vanessa Bonazzi, Deborah Smith

|Jul 22, 2022
Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma.

Asmerom T Sengal, Deborah Smith, Cameron E Snell

|Apr 30, 2021
Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer.

Asmerom T Sengal, Deborah Smith, Rebecca Rogers

|May 17, 2020
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.

Asmerom T Sengal, Ann-Marie Patch, Cameron E Snell

|Dec 02, 2017
Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.

Asmerom Tesfamariam Sengal, Nada Suliman Haj-Mukhtar, Ahmed Mohammed Elhaj

Pageof 1

Frequent Collaborators

2 joint publications

Elizabeth D Williams

1 joint publications

Cameron E Snell

1 joint publications

Aline Talhouk

1 joint publications

Jessica N McAlpine